WO2003010510A3 - Adjunct quantitative system and method for non-invasive measurement of in vivo analytes - Google Patents

Adjunct quantitative system and method for non-invasive measurement of in vivo analytes Download PDF

Info

Publication number
WO2003010510A3
WO2003010510A3 PCT/US2002/023348 US0223348W WO03010510A3 WO 2003010510 A3 WO2003010510 A3 WO 2003010510A3 US 0223348 W US0223348 W US 0223348W WO 03010510 A3 WO03010510 A3 WO 03010510A3
Authority
WO
WIPO (PCT)
Prior art keywords
adjunct
patient
invasive measurement
tissue
spectroscopic
Prior art date
Application number
PCT/US2002/023348
Other languages
French (fr)
Other versions
WO2003010510A2 (en
Inventor
Robert G Messerschmidt
James Mansfield
Derek Brand
Jenny E Freeman
Michael J Hopmeier
Original Assignee
Argose Inc
Robert G Messerschmidt
James Mansfield
Derek Brand
Jenny E Freeman
Michael J Hopmeier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Argose Inc, Robert G Messerschmidt, James Mansfield, Derek Brand, Jenny E Freeman, Michael J Hopmeier filed Critical Argose Inc
Priority to AU2002355272A priority Critical patent/AU2002355272A1/en
Publication of WO2003010510A2 publication Critical patent/WO2003010510A2/en
Publication of WO2003010510A3 publication Critical patent/WO2003010510A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1495Calibrating or testing of in-vivo probes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Optics & Photonics (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Emergency Medicine (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

Abstract

The invention is directed to a method and apparatus for detecting and measuring the concentration of an analyte in a tissue and a patient. Particularly, the invention is directed to methods wherein a spectroscopic measurement is combined with an adjunct spectroscopic or non-spectroscopic measurement to provide a more accurate measure of the analyte. The non-spectroscopic measurements include adjunct spectral measurements, adjunct physiological measurements of the patient, the tissue or the patient from whom the tissue was obtained, or adjunct informational determinants. Preferably these methods can be used for determining the level of glucose in a patient and for enhancing a calibration system.
PCT/US2002/023348 2001-07-25 2002-07-24 Adjunct quantitative system and method for non-invasive measurement of in vivo analytes WO2003010510A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002355272A AU2002355272A1 (en) 2001-07-25 2002-07-24 Adjunct quantitative system and method for non-invasive measurement of in vivo analytes

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30738901P 2001-07-25 2001-07-25
US60/307,389 2001-07-25

Publications (2)

Publication Number Publication Date
WO2003010510A2 WO2003010510A2 (en) 2003-02-06
WO2003010510A3 true WO2003010510A3 (en) 2004-02-19

Family

ID=23189546

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/023348 WO2003010510A2 (en) 2001-07-25 2002-07-24 Adjunct quantitative system and method for non-invasive measurement of in vivo analytes

Country Status (2)

Country Link
AU (1) AU2002355272A1 (en)
WO (1) WO2003010510A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9599599B2 (en) 2011-04-06 2017-03-21 Fresenius Medical Care Holdings, Inc. Measuring chemical properties of a sample fluid in dialysis systems

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6591122B2 (en) 2001-03-16 2003-07-08 Nellcor Puritan Bennett Incorporated Device and method for monitoring body fluid and electrolyte disorders
US7239902B2 (en) 2001-03-16 2007-07-03 Nellor Puritan Bennett Incorporated Device and method for monitoring body fluid and electrolyte disorders
US7751594B2 (en) 2003-04-04 2010-07-06 Lumidigm, Inc. White-light spectral biometric sensors
WO2004097365A2 (en) * 2003-04-30 2004-11-11 Mcgill University Method and system for measuring lactate levels in vivo
US7039448B2 (en) * 2003-05-02 2006-05-02 Diramed, Llc Zero corrected optical blood analyte detector
JP3566276B1 (en) 2003-05-07 2004-09-15 株式会社日立製作所 Blood glucose meter
JP3566277B1 (en) 2003-06-23 2004-09-15 株式会社日立製作所 Blood glucose meter
JP3566278B1 (en) 2003-07-11 2004-09-15 株式会社日立製作所 Blood glucose meter
JP3590047B1 (en) 2003-09-24 2004-11-17 株式会社日立製作所 Optical measuring device and blood glucose measuring device using the same
EP1522254A1 (en) * 2003-10-08 2005-04-13 Hitachi, Ltd. Blood sugar level measuring method and apparatus
JP3557424B1 (en) 2004-02-17 2004-08-25 株式会社日立製作所 Blood glucose meter
JP3557425B1 (en) 2004-02-17 2004-08-25 株式会社日立製作所 Blood glucose meter
JP3590054B1 (en) 2004-02-26 2004-11-17 株式会社日立製作所 Blood glucose measurement device
US8229185B2 (en) 2004-06-01 2012-07-24 Lumidigm, Inc. Hygienic biometric sensors
US7251517B2 (en) 2004-06-30 2007-07-31 Hitachi, Ltd. Blood sugar level measuring apparatus
US7215983B2 (en) 2004-06-30 2007-05-08 Hitachi, Ltd. Blood sugar level measuring apparatus
US8787630B2 (en) 2004-08-11 2014-07-22 Lumidigm, Inc. Multispectral barcode imaging
JP2006115948A (en) * 2004-10-19 2006-05-11 Hitachi Ltd Blood-sugar level measuring apparatus
US7995808B2 (en) 2006-07-19 2011-08-09 Lumidigm, Inc. Contactless multispectral biometric capture
US8355545B2 (en) 2007-04-10 2013-01-15 Lumidigm, Inc. Biometric detection using spatial, temporal, and/or spectral techniques
US8175346B2 (en) 2006-07-19 2012-05-08 Lumidigm, Inc. Whole-hand multispectral biometric imaging
US8180419B2 (en) * 2006-09-27 2012-05-15 Nellcor Puritan Bennett Llc Tissue hydration estimation by spectral absorption bandwidth measurement
WO2008134135A2 (en) 2007-03-21 2008-11-06 Lumidigm, Inc. Biometrics based on locally consistent features
EP2194846A4 (en) 2007-09-13 2013-05-22 Univ Missouri Optical device components
BRPI0818177B1 (en) 2007-10-04 2022-09-27 The Curators Of The University Of Missouri DEVICE
US7961305B2 (en) 2007-10-23 2011-06-14 The Curators Of The University Of Missouri Optical device components
BRPI0909825B8 (en) 2008-03-25 2021-06-22 Univ Missouri method and systems for non-invasive blood glucose detection using spectral data from one or more non-glucose components
EP2299900B1 (en) 2008-05-22 2017-06-07 St. Louis Medical Devices, Inc. Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis
EP2413784A4 (en) 2009-04-01 2014-01-22 Univ Missouri Optical spectroscopy device for non-invasive blood glucose detection and associated method of use
US20110028806A1 (en) * 2009-07-29 2011-02-03 Sean Merritt Reflectance calibration of fluorescence-based glucose measurements
DE112010003414T5 (en) 2009-08-26 2012-12-06 Lumidigm, Inc. Biometric multiplex imaging and biometric dual imager sensor
US8570149B2 (en) 2010-03-16 2013-10-29 Lumidigm, Inc. Biometric imaging using an optical adaptive interface
WO2016054079A1 (en) 2014-09-29 2016-04-07 Zyomed Corp. Systems and methods for blood glucose and other analyte detection and measurement using collision computing
US9554738B1 (en) 2016-03-30 2017-01-31 Zyomed Corp. Spectroscopic tomography systems and methods for noninvasive detection and measurement of analytes using collision computing
EP3484365B1 (en) * 2016-07-18 2022-03-02 GlucoVista Inc. Substance concentration analysis methods and apparatuses
CN107714049A (en) * 2017-09-08 2018-02-23 上海乐糖信息科技有限公司 Noninvasive Blood Glucose Detection Methods, system and device based on Multi-information acquisition
US11141083B2 (en) 2017-11-29 2021-10-12 Samsung Electronics Co., Ltd. System and method for obtaining blood glucose concentration using temporal independent component analysis (ICA)
CN111150395A (en) * 2020-01-15 2020-05-15 桂林电子科技大学 Self-adaptive blood glucose measuring method based on bioelectrical impedance
EP3895603A1 (en) * 2020-04-14 2021-10-20 Biosensors Beyond Borders Ltd Monitoring device
WO2023052843A1 (en) * 2021-10-01 2023-04-06 Rockley Photonics Limited Biomarker value calculation method
CN116889395B (en) * 2023-08-24 2024-02-13 迈德医疗科技(深圳)有限公司 Noninvasive blood glucose meal classification method and system based on CATPCA

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5665962A (en) * 1994-04-19 1997-09-09 Fuji Photo Film Co., Ltd. Image reader and image recorder with interposed photochromic material for reducing flare
US5985214A (en) * 1997-05-16 1999-11-16 Aurora Biosciences Corporation Systems and methods for rapidly identifying useful chemicals in liquid samples

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5665962A (en) * 1994-04-19 1997-09-09 Fuji Photo Film Co., Ltd. Image reader and image recorder with interposed photochromic material for reducing flare
US5985214A (en) * 1997-05-16 1999-11-16 Aurora Biosciences Corporation Systems and methods for rapidly identifying useful chemicals in liquid samples

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9599599B2 (en) 2011-04-06 2017-03-21 Fresenius Medical Care Holdings, Inc. Measuring chemical properties of a sample fluid in dialysis systems

Also Published As

Publication number Publication date
AU2002355272A1 (en) 2003-02-17
WO2003010510A2 (en) 2003-02-06

Similar Documents

Publication Publication Date Title
WO2003010510A3 (en) Adjunct quantitative system and method for non-invasive measurement of in vivo analytes
Marbach et al. Noninvasive blood glucose assay by near-infrared diffuse reflectance spectroscopy of the human inner lip
AU2001291084A1 (en) Minimizing spectral effects during nir-based blood analyte determination
WO2002057740A3 (en) Use of targeted glycemic profiles in the calibration of a noninvasive blood glucose monitor
AU2001272327A1 (en) Method and device for detecting substances in body fluids by raman spectroscopy
Maruo et al. In vivo noninvasive measurement of blood glucose by near-infrared diffuse-reflectance spectroscopy
US7343185B2 (en) Measurement of body compounds
MXPA04008713A (en) Compact apparatus for noninvasive measurement of glucose through near-infrared spectroscopy.
WO2002065090A3 (en) Noninvasive measurement of glucose through the optical properties of tissue
EP1260815A3 (en) Methods for automatically monitoring analyte concentration using minimally invasive devices
WO2004063713A3 (en) Non-invasive determination of direction and rate of change of an analyte
WO2003087759A3 (en) Non-invasive spectroscopic measurement of analytes using a matched reference analyte
WO2001084122A3 (en) Methods and apparatus for spectroscopic calibration model transfer
US8426819B2 (en) Method for the non-invasive optic determination of the temperature of a medium
SG115538A1 (en) Physiological sample collection devices and methods of using the same
WO2003079900A1 (en) Noninvasive blood component value measuring instrument and method
Tenhunen et al. Non-invasive glucose measurement based on selective near infrared absorption; requirements on instrumentation and spectral range
TW200745543A (en) System and methods for providing corrected analyte concentration measurements
WO2007017266A3 (en) Medical measuring device
ATE352252T1 (en) METHOD FOR NON-INVASIVE ANALYTE MEASUREMENT
DE69910003D1 (en) MONITORING PHYSIOLOGICAL ANALYTES
WO2005099567A3 (en) Compact apparatus for noninvasive measurement of glucose through near-infrared spectroscopy
DE69910007D1 (en) DEVICE FOR PREDICTING PHYSIOLOGICAL MEASURED VALUES
WO2006130854A3 (en) Use of multiple data points and filtering in an analyte sensor
MXPA02010106A (en) Determination of sample volume adequacy in biosensor devices.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ PL PT RO RU SE SG SI SK SL TJ TM TR TT TZ UA US UZ VN YU ZA

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP